NCT00144612View on ClinicalTrials.gov

Long-term Treatment Study of MRA for Systemic Juvenile Idiopathic Arthritis (sJIA)

PHASE3CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

July 31, 2004

Primary Completion Date

June 30, 2005

Study Completion Date

June 30, 2009

Conditions
Systemic Juvenile Idiopathic Arthritis
Interventions
DRUG

MRA(Tocilizumab)

8mg/kg/2weeks

Sponsors
All Listed Sponsors
lead

Chugai Pharmaceutical

INDUSTRY

NCT00144612 - Long-term Treatment Study of MRA for Systemic Juvenile Idiopathic Arthritis (sJIA) | Biotech Hunter | Biotech Hunter